Abiopharma

New Form 8-K - Entero Therapeutics, Inc. Filed: 2025-07-02 AccNo: 0001104659-25-065274 Size: 206 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 4 - Bolt Biotherapeutics, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-092941 Size: 5 KB

New Form 4 - EyePoint Pharmaceuticals, Inc. Filed: 2025-07-02 AccNo: 0001562180-25-005229 Size: 29 KB

New Form 4 - TAO Synergies Inc. Filed: 2025-07-02 AccNo: 0001104659-25-065275 Size: 6 KB

New Form 4 - Bolt Biotherapeutics, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-092938 Size: 5 KB

New Form 4 - Bolt Biotherapeutics, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-092937 Size: 5 KB

New Form 4 - Bolt Biotherapeutics, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-092939 Size: 5 KB

New Form 4 - Bolt Biotherapeutics, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-092940 Size: 5 KB

Integer Holdings Corporation - Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

New Form 4 - TAO Synergies Inc. Filed: 2025-07-02 AccNo: 0001104659-25-065272 Size: 6 KB

Hologic - Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

New Form 144 - BICYCLE THERAPEUTICS PLC Filed: 2025-07-02 AccNo: 0001972481-25-000132 Size: 5 KB